Re: Using estimated GFR values to identify patients at risk from iodinated contrast-induced nephropathy

Comment

J D Dyer et al. Clin Radiol. 2007 Mar.

. 2007 Mar;62(3):285; author reply 285.

doi: 10.1016/j.crad.2006.08.018.

No abstract available

Comment on

Using estimated GFR values to identify patients at risk from iodinated contrast induced nephropathy.
Adair W, Harris K, Entwisle J. Adair W, et al. Clin Radiol. 2006 Aug;61(8):714-5. doi: 10.1016/j.crad.2006.03.013. Clin Radiol. 2006. PMID: 16843758 No abstract available.

Using estimated GFR values to identify patients at risk from iodinated contrast induced nephropathy.
Adair W, Harris K, Entwisle J. Adair W, et al. Clin Radiol. 2006 Aug;61(8):714-5. doi: 10.1016/j.crad.2006.03.013. Clin Radiol. 2006. PMID: 16843758 No abstract available.
Water for contrast-induced nephropathy? A thirst for knowledge.
Pate GE, Webb JG. Pate GE, et al. J Invasive Cardiol. 2003 Dec;15(12):703-5. J Invasive Cardiol. 2003. PMID: 14660822 No abstract available.
Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention.
Nyman U, Björk J, Aspelin P, Marenzi G. Nyman U, et al. Acta Radiol. 2008 Jul;49(6):658-67. doi: 10.1080/02841850802050762. Acta Radiol. 2008. PMID: 18568558
[Guideline 'Precautionary measures for contrast media containing iodine'].
van Dijk Azn R, Wetzels JF, ten Dam MA, Aarts NJ, Schimmelpenninck-Scheiffers ML, Freericks MP, Said SA, Geenen RW, Stuurman A, van Everdingen JJ. van Dijk Azn R, et al. Ned Tijdschr Geneeskd. 2008 Mar 29;152(13):742-6. Ned Tijdschr Geneeskd. 2008. PMID: 18461890 Review. Dutch.
Contrast safety in the cancer patient: preventing contrast-induced nephropathy.
Heiken JP. Heiken JP. Cancer Imaging. 2008 Oct 4;8 Spec No A(Spec Iss A):S124-7. doi: 10.1102/1470-7330.2008.9018. Cancer Imaging. 2008. PMID: 18852085 Free PMC article. Review.